5-(1-(4-Chlorobenzyl)-2-methyl-1H-indol-3-yl)-3-(pyridin-4-yl)-4,5-dihydroisoxazole

ID: ALA4248105

PubChem CID: 145983601

Max Phase: Preclinical

Molecular Formula: C24H20ClN3O

Molecular Weight: 401.90

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(C2CC(c3ccncc3)=NO2)c2ccccc2n1Cc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C24H20ClN3O/c1-16-24(23-14-21(27-29-23)18-10-12-26-13-11-18)20-4-2-3-5-22(20)28(16)15-17-6-8-19(25)9-7-17/h2-13,23H,14-15H2,1H3

Standard InChI Key:  NSNLIHHZBKOFEZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    2.5327  -29.7573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5316  -30.5768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2396  -30.9858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2378  -29.3484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9464  -29.7537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9467  -30.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7297  -30.8310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2134  -30.1649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7292  -29.4991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1301  -28.7874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9512  -28.8095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2244  -28.0397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5767  -27.5419    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9032  -28.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0411  -28.0363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4505  -28.7441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2664  -28.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6725  -28.0315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2569  -27.3237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4423  -27.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7215  -31.6476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0098  -32.0491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3089  -31.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5976  -32.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5891  -32.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2977  -33.2637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0060  -32.8604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8779  -33.2507    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.0306  -30.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  7 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 25 28  1  0
  8 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4248105

    ---

Associated Targets(Human)

LNCaP C4-2 (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.90Molecular Weight (Monoisotopic): 401.1295AlogP: 5.91#Rotatable Bonds: 4
Polar Surface Area: 39.41Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.87CX LogP: 5.27CX LogD: 5.27
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.13

References

1. Chaitanya MVSK, Reddy POV, Nikhil K, Kumar A, Shah K, Kumar D..  (2018)  Synthesis and anticancer activity studies of indolylisoxazoline analogues.,  28  (17): [PMID:30072225] [10.1016/j.bmcl.2018.07.035]

Source